tradingkey.logo

Evotec SE

EVO
3.530USD
+0.010+0.28%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.25BMarktkapitalisierung
VerlustKGV TTM

Evotec SE

3.530
+0.010+0.28%

mehr Informationen über Evotec SE Unternehmen

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SE Informationen

BörsenkürzelEVO
Name des UnternehmensEvotec SE
IPO-datumOct 11, 1999
CEOWojczewski (Christian)
Anzahl der mitarbeiter4827
WertpapierartDepository Receipt
GeschäftsjahresendeOct 11
AddresseEssener Bogen 7
StadtHAMBURG
BörseNASDAQ OMX - NASDAQ BASIC
LandGermany
Postleitzahl22419
Telefon4940560810
Websitehttps://www.evotec.com/
BörsenkürzelEVO
IPO-datumOct 11, 1999
CEOWojczewski (Christian)

Führungskräfte von Evotec SE

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
Andere
37.16M
4.31%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Feb 6
Aktualisiert: Fri, Feb 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.40%
BlackRock Institutional Trust Company, N.A.
0.36%
DCF Advisers, LLC
0.34%
WCM Investment Management
0.08%
Andere
97.52%
Aktionäre
Aktionäre
Anteil
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.40%
BlackRock Institutional Trust Company, N.A.
0.36%
DCF Advisers, LLC
0.34%
WCM Investment Management
0.08%
Andere
97.52%
Aktionärstypen
Aktionäre
Anteil
Sovereign Wealth Fund
1.29%
Investment Advisor
0.93%
Investment Advisor/Hedge Fund
0.42%
Family Office
0.05%
Hedge Fund
0.04%
Research Firm
0.01%
Andere
97.25%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
76
9.39M
2.97%
--
2025Q3
77
9.39M
2.97%
-16.64K
2025Q2
74
9.40M
2.85%
+334.04K
2025Q1
60
9.08M
2.82%
-923.30K
2024Q4
59
8.93M
2.90%
+634.42K
2024Q3
56
8.37M
3.36%
+770.57K
2024Q2
55
7.62M
2.73%
+2.19M
2024Q1
54
5.00M
2.98%
-5.56M
2023Q4
57
5.71M
1.76%
+4.47M
2023Q3
51
1.23M
1.80%
-162.10K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Sep 30, 2025
Wellington Management Company, LLP
1.43M
0.4%
+224.34K
+18.61%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.27M
0.36%
-42.77K
-3.25%
Sep 30, 2025
DCF Advisers, LLC
1.20M
0.34%
+84.50K
+7.58%
Sep 30, 2025
WCM Investment Management
300.28K
0.08%
+2.37K
+0.80%
Sep 30, 2025
Parametric Portfolio Associates LLC
224.96K
0.06%
-78.54K
-25.88%
Sep 30, 2025
Pitcairn
161.77K
0.05%
-99.41K
-38.06%
Sep 30, 2025
Citadel Advisors LLC
96.05K
0.03%
+62.47K
+186.07%
Sep 30, 2025
LPL Financial LLC
75.66K
0.02%
+37.82K
+99.92%
Sep 30, 2025
Envestnet Asset Management, Inc.
75.71K
0.02%
-15.95K
-17.40%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Biotechnology ETF
0.08%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
Anteil0.08%
ActivePassive International Equity ETF
Anteil0%
DFA Dimensional Intl Sustainability Core 1 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI